Status:
UNKNOWN
Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease
Lead Sponsor:
Combined Military Hospital Quetta
Conditions:
Vestibular Disorder Preservation
Eligibility:
All Genders
24-65 years
Phase:
NA
Brief Summary
Intractable symptoms of Meniere's disease will be treated with intratympanic steroids. At the same time intratympanic dexamethasone will be used to rescue hearing
Detailed Description
For Alleviation of Intractable symptoms of Meniere's disease will be treated with intratympanic steroids. Measured with pre and post therapy vestibular severity index. At the same time intratympanic ...
Eligibility Criteria
Inclusion
- All patients of unilateral Meniere's disease with severe vestibular symptoms
Exclusion
- Bilateral disease, operated cases
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2022
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT05355610
Start Date
April 1 2021
End Date
May 30 2022
Last Update
May 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CMH Quetta
Quetta, Balochistan, Pakistan, 87300